Dyne Therapeutics, Inc. DYN Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Dyne Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s return on equity?
- Dyne Therapeutics, Inc. (DYN) reported return on equity of -58.9% in Q1 2026.
- How has Dyne Therapeutics, Inc.'s return on equity changed year-over-year?
- Dyne Therapeutics, Inc.'s return on equity increased by 8.0% year-over-year, from -64% to -58.9%.
- What is the long-term trend for Dyne Therapeutics, Inc.'s return on equity?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s return on equity has grown at a 10.8% compound annual growth rate (CAGR), from -33.4% to -55.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.